Use of Cytoglobin in Preparation of Drug for Preventing and/or Treating Diabetes

Abstract

Use of cytoglobin in preparation of a drug for preventing and/or treating diabetes mellitus. The preventing and/or treating includes at least one selected from the group consisting of: (1) reducing a blood glucose level; (2) reducing a total cholesterol level; (3) reducing a triglyceride level; (4) reducing a low-density lipoprotein (LDL) level; (5) improving and restoring a normal morphological structure of a pancreatic tissue; (6) promoting proliferation of a pancreatic β-cell; (7) promoting insulin and glucagon secretion by pancreatic islets; and (8) improving renal steatosis and inflammatory cell infiltration.

Dependencies are inferred from the claim text.